Motaganahalli S, et al. - The utility of faecal calprotectin (FC) in clinical decision-making and on healthcare costs in inflammatory bowel disease (IBD) was evaluated in this analysis. Researchers collected retrospective data including colonoscopy/ other investigations, medication, admission and surgical from hospital records. According to the findings obtained, an introduction of FC into routine IBD care supported changes in clinical management in a similar proportion, yet at potentially half the total cost, compared to a historical colonoscopy-only cohort at the same centre.